Skip to main content
Top
Published in: Malaria Journal 1/2008

Open Access 01-12-2008 | Review

The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence

Authors: Zulfiqarali G Premji, Salim Abdulla, Bernhards Ogutu, Alice Ndong, Catherine O Falade, Issaka Sagara, Nathan Mulure, Obiyo Nwaiwu, Gilbert Kokwaro

Published in: Malaria Journal | Issue 1/2008

Login to get access

Abstract

A fixed-dose combination of artemether-lumefantrine (AL, Coartem®) has shown high efficacy, good tolerability and cost-effectiveness in adults and children with uncomplicated malaria caused by Plasmodium falciparum. Lumefantrine bioavailability is enhanced by food, particularly fat.
As the fat content of sub-Saharan African meals is approximately a third that of Western countries, it raises the question of whether fat consumption by African patients is sufficient for good efficacy. Data from healthy volunteers have indicated that drinking 36 mL soya milk (containing only 1.2 g of fat) results in 90% of the lumefantrine absorption obtained with 500 mL milk (16 g fat). African diets are typically based on a carbohydrate staple (starchy root vegetables, fruit [plantain] or cereals) supplemented by soups, relishes and sauces derived from vegetables, pulses, nuts or fish. The most important sources of dietary fat in African countries are oil crops (e.g. peanuts, soya beans) and cooking oils as red palm, peanut, coconut and sesame oils. Total fat intake in the majority of subSaharan countries is estimated to be in the range 30–60 g/person/day across the whole population (average 43 g/person/day). Breast-feeding of infants up to two years of age is standard, with one study estimating a fat intake of 15–30 g fat/day from breast milk up to the age of 18 months. Weaning foods typically contain low levels of fat, and the transition from breast milk to complete weaning is associated with a marked reduction in dietary fat. Nevertheless, fat intake >10 g/day has been reported in young children post-weaning. A randomized trial in Uganda reported no difference in the efficacy of AL between patients receiving supervised meals with a fixed fat content (~23 g fat) or taking AL unsupervised, suggesting that fat intake at home was sufficient for optimal efficacy. Moreover, randomized trials in African children aged 5–59 months have shown similar high cure rates to those observed in older populations, indicating that food consumption is adequate post-weaning. In conclusion, it appears that only a very small amount of dietary fat is necessary to ensure optimal efficacy with AL and that the fat content of standard meals or breast milk in sub-Saharan Africa is adequate.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization: Guidelines for treatment of malaria. 2006, Geneva: World Health Organization World Health Organization: Guidelines for treatment of malaria. 2006, Geneva: World Health Organization
2.
go back to reference White NJ, van Vugt M, Ezzet F: Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet. 1999, 37: 105-125. 10.2165/00003088-199937020-00002.CrossRefPubMed White NJ, van Vugt M, Ezzet F: Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet. 1999, 37: 105-125. 10.2165/00003088-199937020-00002.CrossRefPubMed
3.
go back to reference Makanga M, Premji Z, Falade C, Karbwang J, Mueller EA, Andriano K, Hunt P, De Palacios PI: Efficacy and safety of the six-dose regimen of arthemeter-lumefrantrine in pediatrics with uncomplicated Plasmodium fulciparum malaria: a pooled analysis of individual patient data. Am J Trop Med Hyg. 2006, 74: 991-998.PubMed Makanga M, Premji Z, Falade C, Karbwang J, Mueller EA, Andriano K, Hunt P, De Palacios PI: Efficacy and safety of the six-dose regimen of arthemeter-lumefrantrine in pediatrics with uncomplicated Plasmodium fulciparum malaria: a pooled analysis of individual patient data. Am J Trop Med Hyg. 2006, 74: 991-998.PubMed
4.
go back to reference Falade C, Makanga M, Premji Z, Ortmann CE, Stockmeyer M, de Palacios PI: Efficacy and safety of artemether-lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg. 2005, 99: 459-467. 10.1016/j.trstmh.2004.09.013.CrossRefPubMed Falade C, Makanga M, Premji Z, Ortmann CE, Stockmeyer M, de Palacios PI: Efficacy and safety of artemether-lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg. 2005, 99: 459-467. 10.1016/j.trstmh.2004.09.013.CrossRefPubMed
5.
go back to reference Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ: Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA. 2007, 297: 2210-2219. 10.1001/jama.297.20.2210.CrossRefPubMed Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ: Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA. 2007, 297: 2210-2219. 10.1001/jama.297.20.2210.CrossRefPubMed
6.
go back to reference Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor W, Checchi F, Guthmann JP: Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomized trial. Lancet. 2005, 365: 1467-1473. 10.1016/S0140-6736(05)66416-1.CrossRefPubMed Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor W, Checchi F, Guthmann JP: Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomized trial. Lancet. 2005, 365: 1467-1473. 10.1016/S0140-6736(05)66416-1.CrossRefPubMed
7.
go back to reference Abdulla S, Sagara I, Borrmann S, D'Alessandro U, González R, Hamel M, Ogutu B, Mårtensson A, Lyimo J, Maiga H, Sasi P, Nahum A, Bassat Q, Juma E, Otieno L, Björkman A, Beck HP, Andriano K, Cousin M, Lefèvre G, Ubben D, Premji Z: Efficacy and safety of artemether-lumefantrine dispersible tablet in African infants and children with uncomplicated malaria : a randomised, investigator-blinded, multi-centre comparison with the crushed commercial tablet. Lancet. 2008, Abdulla S, Sagara I, Borrmann S, D'Alessandro U, González R, Hamel M, Ogutu B, Mårtensson A, Lyimo J, Maiga H, Sasi P, Nahum A, Bassat Q, Juma E, Otieno L, Björkman A, Beck HP, Andriano K, Cousin M, Lefèvre G, Ubben D, Premji Z: Efficacy and safety of artemether-lumefantrine dispersible tablet in African infants and children with uncomplicated malaria : a randomised, investigator-blinded, multi-centre comparison with the crushed commercial tablet. Lancet. 2008,
8.
go back to reference Wiseman V, Kim M, Mutabingwa TK, Whitty CJ: Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS Med. 2006, 3: e373-10.1371/journal.pmed.0030373.PubMedCentralCrossRefPubMed Wiseman V, Kim M, Mutabingwa TK, Whitty CJ: Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS Med. 2006, 3: e373-10.1371/journal.pmed.0030373.PubMedCentralCrossRefPubMed
9.
go back to reference Chanda P, Masiye F, Chitah BM, Sipilanyambe N, Hawela N, Banda P, Okorosobo T: A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia. Malar J. 2007, 6: 21-10.1186/1475-2875-6-21.PubMedCentralCrossRefPubMed Chanda P, Masiye F, Chitah BM, Sipilanyambe N, Hawela N, Banda P, Okorosobo T: A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia. Malar J. 2007, 6: 21-10.1186/1475-2875-6-21.PubMedCentralCrossRefPubMed
11.
go back to reference Lefèvre G, Thomsen MS: Clinical pharmacokinetics of artemether and lumefantrine (Riamet®). Clin Drug Invest. 1999, 18: 467-480. 10.2165/00044011-199918060-00006.CrossRef Lefèvre G, Thomsen MS: Clinical pharmacokinetics of artemether and lumefantrine (Riamet®). Clin Drug Invest. 1999, 18: 467-480. 10.2165/00044011-199918060-00006.CrossRef
12.
go back to reference Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ: Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother. 2000, 44: 697-704. 10.1128/AAC.44.3.697-704.2000.PubMedCentralCrossRefPubMed Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ: Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother. 2000, 44: 697-704. 10.1128/AAC.44.3.697-704.2000.PubMedCentralCrossRefPubMed
13.
go back to reference Schmidt LE, Dalhoff K: Food-drug interactions. Drugs. 2002, 62: 1481-1502. 10.2165/00003495-200262100-00005.CrossRefPubMed Schmidt LE, Dalhoff K: Food-drug interactions. Drugs. 2002, 62: 1481-1502. 10.2165/00003495-200262100-00005.CrossRefPubMed
14.
go back to reference Ezzet F, Mull R, Karbwang J: Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. Br J Clin Pharmacol. 1998, 46: 553-561. 10.1046/j.1365-2125.1998.00830.x.PubMedCentralCrossRefPubMed Ezzet F, Mull R, Karbwang J: Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. Br J Clin Pharmacol. 1998, 46: 553-561. 10.1046/j.1365-2125.1998.00830.x.PubMedCentralCrossRefPubMed
15.
go back to reference Ashley EA, Stepniewska K, Lindegårdh N, Annerberg A, Kham A, Brockman A, Singhasivanon P, White NJ, Nosten F: How much fat is necessary to optimize lumefantrine oral bioavailability?. Trop Med Int Health. 2007, 12: 195-200.CrossRefPubMed Ashley EA, Stepniewska K, Lindegårdh N, Annerberg A, Kham A, Brockman A, Singhasivanon P, White NJ, Nosten F: How much fat is necessary to optimize lumefantrine oral bioavailability?. Trop Med Int Health. 2007, 12: 195-200.CrossRefPubMed
20.
go back to reference Prentice A, Prentice AM, Whitehead RG: Breast-milk fat concentrations of rural African women. 2. Long-term variations within a community. Br J Nutr. 1981, 45: 495-503. 10.1079/BJN19810128.CrossRefPubMed Prentice A, Prentice AM, Whitehead RG: Breast-milk fat concentrations of rural African women. 2. Long-term variations within a community. Br J Nutr. 1981, 45: 495-503. 10.1079/BJN19810128.CrossRefPubMed
21.
go back to reference Kent JC, Mitoulas LR, Cregan MD, Ramsay DT, Doherty DA, Hartmann PE: Volume and frequency of breastfeedings and fat content of breast milk throughout the day. Pediatrics. 2006, 117: e387-395. 10.1542/peds.2005-1417.CrossRefPubMed Kent JC, Mitoulas LR, Cregan MD, Ramsay DT, Doherty DA, Hartmann PE: Volume and frequency of breastfeedings and fat content of breast milk throughout the day. Pediatrics. 2006, 117: e387-395. 10.1542/peds.2005-1417.CrossRefPubMed
22.
go back to reference Larnkjaer A, Schack-Nielsen L, Michaelsen KF: Fat content in human milk according to duration of lactation. Pediatrics. 2006, 117: 988-989. 10.1542/peds.2005-2929.CrossRefPubMed Larnkjaer A, Schack-Nielsen L, Michaelsen KF: Fat content in human milk according to duration of lactation. Pediatrics. 2006, 117: 988-989. 10.1542/peds.2005-2929.CrossRefPubMed
23.
go back to reference Liyanage C, Hettiarachchi M, Mangalajeewa P, Malawipathirana S: Adequacy of vitamin A and fat in the breast milk of lactating women in south Sri Lanka. Public Health Nutr. 2008, Liyanage C, Hettiarachchi M, Mangalajeewa P, Malawipathirana S: Adequacy of vitamin A and fat in the breast milk of lactating women in south Sri Lanka. Public Health Nutr. 2008,
24.
go back to reference Prentice AM, Paul AA: Fat and energy needs of children in developing countries. Am J Clin Nutr. 2000, 72 (5 Suppl): 1253S-1265S.PubMed Prentice AM, Paul AA: Fat and energy needs of children in developing countries. Am J Clin Nutr. 2000, 72 (5 Suppl): 1253S-1265S.PubMed
25.
go back to reference Hudson GJ, John PMV, Paul AA: Variation in the composition of Gambian foods; the importance of water in relation to energy and protein content. Ecol Food Nutr. 1980, 10: 9-17.CrossRef Hudson GJ, John PMV, Paul AA: Variation in the composition of Gambian foods; the importance of water in relation to energy and protein content. Ecol Food Nutr. 1980, 10: 9-17.CrossRef
26.
go back to reference Onyango AW, Receveur O, Esrey SA: The contribution of breast milk to toddler diets in western Kenya. Bull World Health Organ. 2002, 80: 292-299.PubMedCentralPubMed Onyango AW, Receveur O, Esrey SA: The contribution of breast milk to toddler diets in western Kenya. Bull World Health Organ. 2002, 80: 292-299.PubMedCentralPubMed
27.
go back to reference von Seidlein L, Jaffar S, Pinder M, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, Greenwood B: Treatment of African children with uncomplicated falciparum. J Infect Dis. 1997, 176: 1113-1116.CrossRefPubMed von Seidlein L, Jaffar S, Pinder M, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, Greenwood B: Treatment of African children with uncomplicated falciparum. J Infect Dis. 1997, 176: 1113-1116.CrossRefPubMed
28.
go back to reference von Seidlein L, Bojang K, Jones P, Jaffar S, Pinder M, Obaro S, Doherty T, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, McAdam K, Greenwood B: A randomized controlled trial of artemether/benflumetol, a new anti-malarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. Am J Trop Med Hyg. 1998, 58: 638-644.PubMed von Seidlein L, Bojang K, Jones P, Jaffar S, Pinder M, Obaro S, Doherty T, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, McAdam K, Greenwood B: A randomized controlled trial of artemether/benflumetol, a new anti-malarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. Am J Trop Med Hyg. 1998, 58: 638-644.PubMed
29.
go back to reference Hatz C, Abdulla S, Mull R, Schellenberg D, Gathmann I, Kibatala P, Beck HP, Tanner M, Royce C: Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1–5 years. Trop Med Int Health. 1998, 3: 498-504. 10.1046/j.1365-3156.1998.00250.x.CrossRefPubMed Hatz C, Abdulla S, Mull R, Schellenberg D, Gathmann I, Kibatala P, Beck HP, Tanner M, Royce C: Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1–5 years. Trop Med Int Health. 1998, 3: 498-504. 10.1046/j.1365-3156.1998.00250.x.CrossRefPubMed
30.
go back to reference Mutabingwa T, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ: Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine +artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet. 2005, 365: 1474-1480. 10.1016/S0140-6736(05)66417-3.CrossRefPubMed Mutabingwa T, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ: Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine +artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet. 2005, 365: 1474-1480. 10.1016/S0140-6736(05)66417-3.CrossRefPubMed
31.
go back to reference Checchi F, Piola P, Fogg P, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor WR: Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetics and dosage-related findings from a clinical trial in Uganda. Malaria J. 2006, 5: 59-10.1186/1475-2875-5-59.CrossRef Checchi F, Piola P, Fogg P, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor WR: Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetics and dosage-related findings from a clinical trial in Uganda. Malaria J. 2006, 5: 59-10.1186/1475-2875-5-59.CrossRef
32.
go back to reference Kabanywanyi AM, Mwita A, Sumari D, Mandike R, Mugittu K, Abdulla S: Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. Malar J. 2007, 6: 146-10.1186/1475-2875-6-146.PubMedCentralCrossRefPubMed Kabanywanyi AM, Mwita A, Sumari D, Mandike R, Mugittu K, Abdulla S: Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. Malar J. 2007, 6: 146-10.1186/1475-2875-6-146.PubMedCentralCrossRefPubMed
33.
go back to reference Koram KA, Abuaku B, Duah N, Quashie N: Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Acta Trop. 2005, 95: 194-203. 10.1016/j.actatropica.2005.06.018.CrossRefPubMed Koram KA, Abuaku B, Duah N, Quashie N: Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Acta Trop. 2005, 95: 194-203. 10.1016/j.actatropica.2005.06.018.CrossRefPubMed
34.
go back to reference Fanello CI, Karema C, van Doren W, Van Overmeir C, Ngamije D, D'Alessandro U: A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Randa. Trans R Soc Trop Med Hyg. 2007, 101: 344-350. 10.1016/j.trstmh.2006.06.010.CrossRefPubMed Fanello CI, Karema C, van Doren W, Van Overmeir C, Ngamije D, D'Alessandro U: A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Randa. Trans R Soc Trop Med Hyg. 2007, 101: 344-350. 10.1016/j.trstmh.2006.06.010.CrossRefPubMed
Metadata
Title
The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence
Authors
Zulfiqarali G Premji
Salim Abdulla
Bernhards Ogutu
Alice Ndong
Catherine O Falade
Issaka Sagara
Nathan Mulure
Obiyo Nwaiwu
Gilbert Kokwaro
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2008
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-7-244

Other articles of this Issue 1/2008

Malaria Journal 1/2008 Go to the issue